Introduction
Laron type dwarfism (LTD)' is a genetic disease caused by extreme resistance to growth hormone (GH) action (1, 2) . Several abnormalities in the GH receptor gene have recently been shown in families with LTD (3) (4) (5) . In a Tunisian family with four children presenting LTD, a point mutation in the GH receptor gene has been identified that generates a Ser in place of a Phe at position 96 in the extracellular domain of the receptor (4) . It was suggested that this mutation results in a functionally inactive GH receptor in these patients. However, Bass et al. (6) reported that the mutated GH binding protein (GHBP) expressed in Escherichia coli has binding characteristics identical to those ofthe wild type BP. Recently, Duquesnoy et al. (7) reported that the Phe to Ser mutation of the human GH receptor expressed in COS-7 cells did not affect binding but rather altered intracellular trafficking of the receptor.
We have expressed the wild type and mutant full-length rabbit GH receptor and the wild type and mutant rabbit and human BPs in COS-7 cells. Our study was extended to include the prolactin receptor that belongs to the GH/prolactin (PRL) receptor family and in which this phenylalanine is conserved (8) . The expression of the receptors was assessed by Western blot and immunofluorescence studies. The binding activity of the expressed receptors was assayed in the transfected cell membranes and medium.
Methods

Materials
The following products were obtained from the cited sources: recombinant human GH (hGH), Serono Laboratories (Boulogne, France); ovine PRL (oPRL), NIDDK- 16 , National Hormone and Pituitary Program (Baltimore, MD); MEM, Ham's F12, transferrin, insulin, glutamine, nonessential amino acids, penicillin, and streptomycin, Flow rbGHR (pBS.rbGHR) and a portion of the hGHR (1,057-bp EcoRI fragment from pBR.hGHR) (10) were subcloned into the vector Ml 3mp 18 and subsequently used to generate single-stranded template in RZ 1032 cells. Phe to Ser mutations were introduced using synthetic oligonucleotides, 25 nucleotides in length, containing a TTT -I TCT/ C mutation in the center of the primer. The soluble secreted forms of both GH receptors were constructed using a 27-nucleotide oligomer designed to introduce a stop codon at amino acid 246, one amino acid before the transmembrane domain. The PRL receptor22 (PRLR22) cDNA (8) encoding the extracellular and transmembrane domains of the rabbit PRL receptor was inserted into Ml3mp19 vector. Sitedirected mutagenesis with synthetic oligonucleotide, 20 nucleotides in length, containing a TTT --TCT/C mutation in the center of the oligonucleotide was performed to introduce a Phe to Ser mutation at position 64. The 1,600-bp fragment of PRLR22 (8) was inserted into pECE expression vector and full-length cDNA was constructed as previously described (8) . The extracellular domain of PRLR was constructed by digesting pECE PRLR22 at the Sacd sites found after the glutamic acid codon that precedes the transmembrane domain and in the polylinker of pECE. The resulting 370-bp SacI-Sacd fragment was separated by gel electrophoresis and the expression plasmid containing coding region of extracellular domain of PRLR was ligated with T4 DNA ligase. Stop codons are present -3' to the polylinker of pECE in all three reading frames, before the SV40 polyadenylation signal and poly (A) tract, which accommodate any 3' truncation of the cDNA.
Cell line COS-7 monkey kidney cells were grown as monolayers in serum-free medium that is a 1:1 mixture of MEM and Ham's F12 supplemented with transferrin (10 Ag/ml), insulin (80 mU/ml), glutamine (2.5 mM), nonessential amino acids, penicillin, and streptomycin (100 U / ml) at 37°C in a 5% CO2 atmosphere.
Membranefraction preparations
Cells were scraped offin 1 ml PBS and centrifuged for 5 min at 2,000 g. After resuspension of the pellet in 0.5 ml 25 mM Tris-HCl, pH 7.4, 10 mM MgCl2 (Tris-Mg buffer), cells were lysed by three freeze-thaw cycles and centrifuged at 17,600 g for 10 min at 4°C. The pellet, referred to as the total particulate fraction, was resuspended in Tris-Mg buffer. Microsomal fractions were prepared by differential centrifugation: after a first centrifugation for 15 min at 2,000 g, the supernatant was centrifuged at 1 00,000 g for 30 min. The pellet was resuspended in Tris-Mg buffer. Membrane fractions were stored in liquid nitrogen until binding measurements. Protein concentrations were determined by the method of Lowry, using BSA as a standard.
Transfection assays COS-7 cells were plated on 100-mm culture dishes and grown to 50% confluency. Cells were transfected either with the wild type or the Phe --Ser mutant by the calcium phosphate precipitation procedure using l0-jug expression plasmid. Cells were harvested 72 h after transfection and the culture medium was collected and concentrated 1 0-fold with CX-I0 immersible cartridges.
Western blots GHR and GH binding protein (GHBP). 100 Ag membrane protein of total particulate fraction or 10 Al of concentrated cell culture medium per lane were separated in a 7.5% polyacrylamide SDS gel according to Laemmli ( 11) (Millipore Corp.) , the entire incubation mixture was injected onto a HPLC Protein Pak 300SW column as described previously ( 14) . Elution was performed isocratically using a degassed buffer (100 mM Na2SO4 and 100 mM potassium phosphate, pH 7.0) pumped at a rate of0.5 ml/min. Binding ofGH is expressed as the radioactivity in the individual peak divided by the total radioactivity in the peaks.
Immunoprecipitation ofPRLBP. To analyze prolactin binding by immunoprecipitation, culture medium (50 ,l) was incubated with
[1251]oPRL (5 x 104 cpm) in the absence or presence of increasing concentrations of unlabeled oPRL in a total volume of 500 Al of Tris buffer(25 mM Tris-HCI, pH 7.5, 10 mM MgCl2, 0.1% BSA). After 16 h at room temperature, polyclonal antibodies (10 ,l of goat serum 46) to the prolactin receptor were added and the incubation was continued for two additional hours. 500 ml y globulin (0.1%) and 1 ml polyethylene glycol (final concentration 12.5%) in phosphate buffer was added. The tubes were centrifuged, the supernatant was discarded, and the radioactivity of the pellet was recorded by a y counter (LKB). 
Results
Expression ofthe GH receptor/BP The full-length rabbit GH receptor and BP were expressed in COS-7 cell membranes and culture medium, respectively. Fig.  1 a shows Western blot analysis using a monoclonal antibody (mAbS) specific to the GH receptor. The expression in COS-7 cell membranes (lanes 2 and 3) is comparable for the wild type and the mutated rabbit GH receptor, which migrate with relative molecular masses of 120,000 and 230,000.
In 
Expression ofthe prolactin receptor/BP
In membranes ofCOS-7 cells transfected with the cDNA ofthe prolactin receptor and analyzed by immunoblot, a single band of 88 kD is detected for both the wild type and the mutated receptor ( Fig. 1 b, lanes 2 and 3) . In concentrated media, the prolactin BPs are expressed; they are detected on the immunoblot as a 38,000 Mr band (lanes 4 and 5).
In the membranes and culture media of COS-7 cells which had not been transfected, no protein appears on the immunoblots, as can be seen in lanes I and 6 of Figs. 1 a and (Table II) ; the expected high affinity is found (Table I) . When the mutated full-length rbGHR is expressed in the cell membranes, no binding activity can be measured, either in total particulate fractions or in microsomes (Table II) As shown in Table I , the wild type full-length PRLR expressed in COS-7 cell membranes has the expected high binding affinity. The PRLBP expressed in the cell culture medium shows an affinity constant which is 11 times higher than that found for the PRLR and which is comparable to that previously reported for the PRLBP present in the rabbit milk ( 17) . No binding activity was present either in cell membrane or in cell culture medium when the mutant forms of the PRLR/BP were expressed.
Discussion
After the demonstration in one family with LTD of a point mutation resulting in the substitution of a Phe by a Ser at position 96 in the extracellular domain ofthe GH receptor (4), two questions were raised: Is the mutated receptor expressed, and is this mutation the cause of the GH resistance in the patients? Our study provides a clear response: it demonstrates that the (8) . Thus, our study was extended to the effect of this point mutation on the expression and binding activity of the PRL receptor.
The GH receptor cloned from rabbit and human liver (10) We have not been able thus far to functionally express the full-length human GHR; for the present studies, cDNAs of the full-length rabbit GH receptor and of GHBPs for rabbit and man were used. In addition, the full-length and binding protein forms of the PRL receptor were also expressed. Replacing Phe 96 with Ser does not alter the expression of the protein. Western blot analyses reveal a protein of 120 kD for the full-length rabbit GHR with the presence of a band of higher molecular weight, probably representing a dimer. The mutant form has the same molecular weight as the wild type receptor. The binding proteins, both wild type and mutant forms, are secreted in the culture media; their molecular mass (56,000) is that expected for GHBPs: The molecular mass of the GHBP present in human plasma has been estimated, in crosslinking experiments, to be 55,000 (21 ) . Oligomerization is the probable explanation for the presence ofhigher molecular weight bands on Western blots of the rabbit GHBP. Several forms have been identified previously for mouse GHBP (22).
For the prolactin receptor also, substitution of this conserved Phe to Ser does not change the protein expression in COS-7 cells. The molecular masses of the full-length receptor and of the BP, 88,000 and 38,000, respectively, are those expected for the two forms (23 (7), who found GH binding activity in a lysosomal fraction prepared from COS-7 cells expressing the mutant hGH receptor. The distribution of the hGH receptor that was presented by these authors and that lead them to conclude that there was an abnormal processing of the mutant receptor is difficult to reconcile with respect to previous studies (24, 25) . Their results showing the complete absence of wild type hGH receptors in a microsomal fraction make the interpretation of their binding studies difficult. Nevertheless, in cells expressing the mutant receptor, they did find some binding activity in a membrane subfraction that remains to be characterized. Thus, from the binding study presented by Duquesnoy et al. (7), it is difficult to draw definitive conclusions on the cell surface or intracellular localization of GH receptors.
On the other hand, we do not agree with the conclusion of Duquesnoy et al. (7) , that the intracellular processing of the mutant receptor is abnormal. Our immunofluorescence studies have clearly shown in nonpermeabilized cells that the weak labeling observed with the anti-GH receptor antibody could be attributed to cell surface receptors. Although this labeling was diffuse, probably because of the inherent activity of the monoclonal antibody and the low number ofcell surface receptors, it was clearly localized at the periphery of the cells. Under these conditions, intracellular antigens were not accessible to antireceptor antibody, as demonstrated by the absence of rhodamine (anti-RER) signal. Moreover, in Triton-treated cells, the images were strikingly different, with an intense signal of the antireceptor antibody in cells expressing both wild type and mutant receptors, probably related to the high concentration of GH receptors in intracellular membrane compartments. The signal was essentially perinuclear, probably corresponding to a localization in the endoplasmic reticulum and Golgi. Such a high proportion of GH receptors in intracellular organelles has already been demonstrated in other models, such as rat hepatocytes (24) . One difference between the studies of Duquesnoy et al. (7) and the present results is that their study was performed on cells expressing the full-length human receptor, while our study used the full-length rabbit receptor. However, based on the observation of several independent COS-7 cell transfections, we conclude that there is no difference in either the intensity or the distribution of the signal between wild type and mutant receptors.
The phenylalanine residue at position 96 is located just after the first four cysteines, a region conserved among GH and PRL receptors, as well as cytokine receptors. This residue occurs at this particular position in the GH and PRL receptors of all species so far studied, suggesting that it could be part of the structural requirements that are crucial for proper ligand binding (26) . However, the extracellular domain of the human GHR, in which Phe 96 had been substituted by a Ser, expressed in E. coli, showed normal GH binding characteristics (6, 27 ). The apparent discrepancy could reside in the choice of the expression model, since the hGHBP was expressed in bacterial cells by Bass et al. (6, 27) , and in mammalian cells in our study. The absence ofglycosylation did not alter GH binding to the wild type receptor, and normal binding was seen for the Phe -> Ser mutant (6) . On the other hand, we now demonstrate that in the mature glycosylated GHBP the phenylalanine residue is important for GH binding. These findings suggest that although the Phe residue may not be directly implicated in the ligand binding domain, it contributes to the conformational integrity of the mature protein. Glycosylation could result in changes in the tertiary folding of the receptor. In GHR, an N-linked glycosylation site (Asn97) is located next to the conserved Phe. Finally, this mutation involves the replacement of a nonpolar residue (Phe) by a polar residue (Ser). In fact, the crystal structure of the hGHBP recently reported (28) shows that Phe 96 is the last residue off-strand E, and that the phenylalanine side chain is indeed packed inside the fl-sheet sandwich of the NH2-terminal domain. It thus seems reasonable to conclude that the Phe 96 to Ser mutation could have a disruptive effect on the structure of this domain, especially in view of the fact that the loop following this residue contains the most important hormone binding determinant, Trp 104 (de Vos, B., personal communication).
In summary, the phenylalanine to serine substitution found in one family of LTD is responsible for GH resistance in these patients. This substitution appears to alter ligand binding activity rather than normal processing ofthe receptor. The phenylalanine residue may be an important structural determinant for hormone binding to the mature GH receptor as well as the PRL receptor (26) . The use of mammalian cells rather than bacterial cells to express GH and PRL receptors to study ligand binding represents a more realistic model for the interpretation of genetic defects of eukaryotes.
